Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?Feng, Rui‐Mei ; Zong, Yi‐Nan ; Cao, Su‐Mei ; Xu, Rui‐HuaCancer communications (London, England), 2019-04, Vol.39 (1), p.1-12 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
|
2 |
Material Type: Artigo
|
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancerWang, Feng‐Hua ; Shen, Lin ; Li, Jin ; Zhou, Zhi‐Wei ; Liang, Han ; Zhang, Xiao‐Tian ; Tang, Lei ; Xin, Yan ; Jin, Jing ; Zhang, Yu‐Jing ; Yuan, Xiang‐Lin ; Liu, Tian‐Shu ; Li, Guo‐Xin ; Wu, Qi ; Xu, Hui‐Mian ; Ji, Jia‐Fu ; Li, Yuan‐Fang ; Wang, Xin ; Yu, Shan ; Liu, Hao ; Guan, Wen‐Long ; Xu, Rui‐HuaCancer communications (London, England), 2019-03, Vol.39 (1), p.1-31 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
|
3 |
Material Type: Artigo
|
Progress in diagnosis and treatment of gynecological tumors in 2022GUO Qinhao, YU Min, WU XiaohuaZhongguo ai zheng za zhi, 2023-01, Vol.33 (1), p.14-24 [Periódico revisado por pares]Editorial Office of China OncologyTexto completo disponível |
|
4 |
Material Type: Artigo
|
Dual prognostic role of 2‐oxoglutarate‐dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenanceChang, Wai Hoong ; Forde, Donall ; Lai, Alvina G.Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-14 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
|
5 |
Material Type: Artigo
|
A systematic review of current advancements of artificial intelligence in genitourinary cancersXU Wenhao, TIAN Xi, Aihetaimujiang·Anwaier , QU Yuanyuan, SHI Guohai, ZHANG Hailiang, YE DingweiZhongguo ai zheng za zhi, 2022-01, Vol.32 (1), p.68-74 [Periódico revisado por pares]Editorial Office of China OncologyTexto completo disponível |
|
6 |
Material Type: Artigo
|
Cancer cell reprogramming: a promising therapy converting malignancy to benignityGong, Lanqi ; Yan, Qian ; Zhang, Yu ; Fang, Xiaona ; Liu, Beilei ; Guan, XinyuanCancer communications (London, England), 2019-08, Vol.39 (1), p.1-13 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
|
7 |
Material Type: Artigo
|
Prevalence of depression and associated factors among adult cancer patients receiving chemotherapy during the era of COVID-19 in Ethiopia. Hospital-based cross-sectional studyBelete, Abebe Muche ; Alemagegn, Anmut ; Mulu, Anemut Tilahun ; Yazie, Taklo Simeneh ; Bewket, Bekalu ; Asefa, Adisu ; Shiferaw, Wendimeneh Shibabaw Akash, Muhammad Sajid HamidPloS one, 2022-06, Vol.17 (6), p.e0270293-e0270293 [Periódico revisado por pares]San Francisco: Public Library of ScienceTexto completo disponível |
|
8 |
Material Type: Artigo
|
Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective StudyAbe, Marina ; Shoji, Tadahiro ; Chiba, Yohei ; Takatori, Eriko ; Kaido, Yoshitaka ; Nagasawa, Takayuki ; Kagabu, Masahiro ; Takahashi, Fumiaki ; Aida, Takeshi ; Baba, TsukasaAnticancer research, 2023-03, Vol.43 (3), p.1265-1272 [Periódico revisado por pares]Greece: International Institute of Anticancer ResearchTexto completo disponível |
|
9 |
Material Type: Artigo
|
The latest progress and prospect of gynecological tumor treatment at 2023 ESMOXIA Lingfang, ZHU Jun, WU XiaohuaZhongguo ai zheng za zhi, 2023-11, Vol.33 (11), p.969-980 [Periódico revisado por pares]Editorial Office of China OncologyTexto completo disponível |
|
10 |
Material Type: Artigo
|
Research progress on application of systemic immune inflammatory index in solid cancersXu Zhaojun, Zhang Chengwu, Ma XiaomingXīn yīxué, 2023-02, Vol.54 (2), p.110-114 [Periódico revisado por pares]Editorial Office of Journal of New MedicineTexto completo disponível |